Synthesis and anticancer activity studies of indolylisoxazoline analogues

dc.contributor.authorKumar, Anil
dc.contributor.authorKumar, Dalip
dc.date.accessioned2021-10-14T13:11:06Z
dc.date.available2021-10-14T13:11:06Z
dc.date.issued2018-07-26
dc.description.abstractA new library of thirteen indolylisoxazolines 6a-m has been synthesized by the treatment of indolylchalcones with hydroxylamine hydrochloride. Evaluation of anticancer activity of indolylisoxazolines 6a-m led to the identification of potent compounds 6c-d, 6i and 6l, with IC50 ranging 2.5-5.0 µM against the tested cancer cell lines. Using a number of complementary techniques such as acridine orange/ethidium bromide staining, PARP1 cleavage and DNA strand breaks assay, we show that the compounds 6c and 6i induce apoptosis in highly aggressive C4-2 cells. Our data further revealed that 6c and 6i inhibited C4-2 cells proliferation without inducing reactive oxygen species (ROS). Finally, we show that compounds 6c and 6i also potently inhibit cell migration, indicating these compounds have the potential to serve as effective anti-cancer agents.en_US
dc.identifier.urihttps://europepmc.org/article/med/30072225
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/2824
dc.language.isoenen_US
dc.publisherPMCen_US
dc.subjectChemistryen_US
dc.subjectSynthesisen_US
dc.subjectIndolylisoxazolineen_US
dc.subjectAnticanceren_US
dc.titleSynthesis and anticancer activity studies of indolylisoxazoline analoguesen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: